What is ACTA Laboratories?
ACTA Laboratories operates as an FDA-registered, DEA-licensed, and cGMP-compliant facility, providing essential analytical chemistry, microbiology, and stability testing services. With a legacy spanning over three decades, the firm serves as a vital partner for both emerging biotech startups and established global corporations. Its operational model is built upon rigorous regulatory adherence, having successfully navigated numerous FDA inspections to ensure that clients maintain the highest standards of product integrity and safety throughout the development lifecycle.
How much funding has ACTA Laboratories raised?
ACTA Laboratories has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in ACTA Laboratories
PPP
Public-Private Partnership
What's next for ACTA Laboratories?
With this late-stage financing, ACTA Laboratories is well-positioned to scale its analytical outsourcing capabilities and expand its footprint within the life sciences sector. The strategic allocation of these funds will likely focus on enhancing laboratory throughput, integrating advanced testing technologies, and further streamlining compliance workflows for its diverse client base. As the demand for outsourced quality control continues to rise, ACTA is poised to leverage its established reputation to capture additional market share and solidify its status as a cornerstone of pharmaceutical quality assurance.
See full ACTA Laboratories company page
